Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
1.093,811.096,521.100,221.091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
1.254,811.253,011.253,871.226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
1.761,111.764,271.766,881.744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
3.211,833.227,213.268,383.226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
1.474,521.479,031.481,041.466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
2.392,122.396,952.421,222.382,32
CATX:NYSEAMERICAN
Perspective Therapeutics Inc
3,85 US$
-1,28%
(-0,050) 1D
3,85 US$
-0,01% (-0,00030)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CATX...
Açın
3,87 US$
High
3,98 US$
Low
3,83 US$
Mkt. cap
438,97 mln
Volume
1,00 mln
52-wk high
6,16 US$
52-wk low
1,96 US$
EPS
-1,40 US$
Beta
1,86
Shares outstanding
114,02 mln
No. of employees
163
News stories
From sources across the web
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSietl, Vaşinqton, Amerika Birləşmiş Ştatları
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
342,00K
290,00K
209,00K
43,00K
Cost of goods sold
14,33 mln
16,62 mln
20,34 mln
32,92 mln
Cost of revenue
14,33 mln
16,62 mln
20,34 mln
32,92 mln
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,84 mln
7,71 mln
7,73 mln
6,95 mln
Operating expense
7,84 mln
7,71 mln
7,73 mln
6,95 mln
Total operating expenses
22,17 mln
24,33 mln
28,07 mln
39,88 mln
Operating income
-21,83 mln
-24,04 mln
-27,86 mln
-39,83 mln
Other non operating income
1,40 mln
-
-
-
EBT including unusual items
-18,18 mln
-22,00 mln
-25,97 mln
-38,28 mln
EBT excluding unusual items
-18,18 mln
-22,00 mln
-25,97 mln
-38,28 mln
Income tax expense
-
-
-
-793,00K
Effective tax rate
-
-
-
2,07%
Other operating expenses
-
-
-
-
Net income
-18,18 mln
-21,48 mln
-25,97 mln
-37,49 mln
Net profit margin
-5.314,91%
-7.408,62%
-12.425,36%
-87.186,05%
Earnings per share
-0,25
-0,30
-0,35
-0,51
Interest and investment income
2,38 mln
2,16 mln
1,96 mln
1,61 mln
Interest expense
-128,00K
-119,00K
-65,00K
-64,00K
Net interest expenses
2,26 mln
2,04 mln
1,89 mln
1,55 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,10 mln
-23,31 mln
-27,09 mln
-38,83 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more